Ruxotor 5 mg (Ruxolitinib Phosphate) is a JAK1/JAK2 inhibitor used to manage myelofibrosis, polycythemia vera, and graft-versus-host disease. It reduces excessive inflammatory signaling, helping relieve symptoms and improve quality of life. Regular blood count monitoring is essential throughout treatment under medical supervision. https://oncologymedi.com/product/ruxotor-5-mg-ruxolitinib-phosphate/